{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "SARS", "Traditional Chinese medicine (TCM)", "drug", "herb", "medicinal plant", "natural products", "viral infection"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33519449", "DateRevised": {"Year": "2023", "Month": "11", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "11"}], "Language": ["eng"], "ELocationID": ["589044", "10.3389/fphar.2020.589044"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "11", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection.", "Pagination": {"StartPage": "589044", "MedlinePgn": "589044"}, "Abstract": {"AbstractText": ["The rapid outbreak of coronavirus disease 2019 (COVID-19) has demonstrated the need for development of new vaccine candidates and therapeutic drugs to fight against the underlying virus, severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Currently, no antiviral treatment is available to treat COVID-19 as treatment is mostly directed to only relieving the symptoms. Retrospectively, herbal medicinal plants have been used for thousands of years as a medicinal alternative including for the treatment of various viral illnesses. However, a comprehensive description using various medicinal plants in treating coronavirus infection has not to date been described adequately, especially their modes of action. Most other reports and reviews have also only focused on selected ethnobotanical herbs such as Traditional Chinese Medicine, yet more plants can be considered to enrich the source of the anti-viral compounds. In this review, we have screened and identified potential herbal medicinal plants as anti-coronavirus medication across major literature databases without being limited to any regions or ethnobotanic criteria. As such we have successfully gathered experimentally validated <i>in vivo</i>, <i>in vitro,</i> or <i>in silico</i> findings of more than 30 plants in which these plant extracts or their related compounds, such as those of <i>Artemisia annua</i> L., <i>Houttuynia cordata</i> Thunb.<i>,</i> and <i>Sambucus formosana</i> Nakai, are described through their respective modes of action against specific mechanisms or pathways during the viral infection. This includes inhibition of viral attachment and penetration, inhibition of viral RNA and protein synthesis, inhibition of viral key proteins such as 3-chymotrypsin-like cysteine protease (3CL<sup>pro</sup>) and papain-like protease 2 (PL<sup>pro</sup>), as well as other mechanisms including inhibition of the viral release and enhanced host immunity. We hope this compilation will help researchers and clinicians to identify the source of appropriate anti-viral drugs from plants in combating COVID-19 and, ultimately, save millions of affected human lives."], "CopyrightInformation": "Copyright \u00a9 2021 Remali and Aizat."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia (UKM), Bangi, Malaysia."}], "LastName": "Remali", "ForeName": "Juwairiah", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia (UKM), Bangi, Malaysia."}], "LastName": "Aizat", "ForeName": "Wan Mohd", "Initials": "WM"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Anand K., Ziebuhr J., Wadhwani P., Mesters J. R., Hilgenfeld R. (2003). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 80, 1763\u20131767. 10.1126/science.1085658", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Belleudi F., Visco V., Ceridono M., Leone L., Muraro R., Frati L., et al. (2003). Ligand-induced clathrin-mediated endocytosis of the keratinocyte growth factor receptor occurs independently of either phosphorylation or recruitment of eps15. FEBS Lett. 553 (3), 262\u2013270. 10.1016/S0014-5793(03)01020-2", "ArticleIdList": ["10.1016/S0014-5793(03)01020-2", "14572635"]}, {"Citation": "Bosch B. J., Bartelink W., Rottier P. J. M. (2008). Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus Class I fusion protein upstream of rather than adjacent to the fusion peptide. J. Virol. 82 (17), 8887\u20138890. 10.1128/jvi.00415-08", "ArticleIdList": ["10.1128/jvi.00415-08", "PMC2519682", "18562523"]}, {"Citation": "Brendler T., van Wyk B. E. (2008). A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae). J. Ethnopharmacol. 119 (3), 420\u2013433. 10.1016/j.jep.2008.07.037", "ArticleIdList": ["10.1016/j.jep.2008.07.037", "18725280"]}, {"Citation": "Cascella M., Rajnik M., Cuomo A., Dulebohn S. C., Di Napoli R. (2020). Features, evaluation and treatment coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing.", "ArticleIdList": ["32150360"]}, {"Citation": "Chang F. R., Yen C. T., Ei-Shazly M., Lin W. H., Yen M. H., Lin K. H., et al. (2012). Anti-human coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia . Nat. Prod. Commun. 7 (11), 1934 10.1177/1934578x1200701103", "ArticleIdList": ["10.1177/1934578x1200701103", "23285797"]}, {"Citation": "Chen C. J., Michaelis M., Hsu H. K., Tsai C. C., Yang K. D., Wu Y. C., et al. (2008). Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J. Ethnopharmacol. 120 (1), 108\u2013111. 10.1016/j.jep.2008.07.048", "ArticleIdList": ["10.1016/j.jep.2008.07.048", "PMC7127248", "18762235"]}, {"Citation": "Chen F., Chan K. H., Jiang Y., Kao R. Y. T., Lu H. T., Fan K. W., et al. (2004). In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 31 (1), 69\u201375. 10.1016/j.jcv.2004.03.003", "ArticleIdList": ["10.1016/j.jcv.2004.03.003", "PMC7128415", "15288617"]}, {"Citation": "Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 28, 526 10.1016/S0140-6736(20)30211-7", "ArticleIdList": ["10.1016/S0140-6736(20)30211-7", "PMC7135076", "32007143"]}, {"Citation": "Chia (2007). Components of Toona Sinensis: review. Rev. Bras. Farmacogn. 29 (1), 111\u2013124. 10.1016/j.bjp.2018.07.009", "ArticleIdList": ["10.1016/j.bjp.2018.07.009", "PMC7103134", "32287507"]}, {"Citation": "Chiou S. Y., Sung J. M., Huang P. W., Lin S. D. (2017). Antioxidant, antidiabetic, and antihypertensive properties of Echinacea purpurea flower extract and caffeic acid derivatives using in vitro models. J. Med. Food 20 (2), 171\u2013179. 10.1089/jmf.2016.3790", "ArticleIdList": ["10.1089/jmf.2016.3790", "28061036"]}, {"Citation": "Chiow K. H., Phoon M. C., Putti T., Tan B. K. H., Chow V. T. (2016). Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac. J. Trop. Med. 9 (1), 1\u20137. 10.1016/j.apjtm.2015.12.002", "ArticleIdList": ["10.1016/j.apjtm.2015.12.002", "PMC7104935", "26851778"]}, {"Citation": "Cho W. K., Kim H., Choi Y. J., Yim N. H., Yang H. J., Ma J. Y. (2012). Epimedium koreanum Nakai water extract exhibits antiviral activity against porcine epidermic diarrhea virus in vitro and in vivo. Evidence-based Complement . Altern. Med. 7 (1), 352\u2013377. 10.1155/2012/985151", "ArticleIdList": ["10.1155/2012/985151", "PMC3521454", "23259003"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H. W. (2003). Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361 (9374), 2045\u20132046. 10.1016/S0140-6736(03)13615-X", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "PMC7112442", "12814717"]}, {"Citation": "Conrad A., Kolodziej H., Schulz V. (2007). Pelargonium sidoides-etrakt (EPs\u00ae 7630): Zulassung best\u00e4tigt wirksamkeit und vertr\u00e4glichkeit. Wien Med. Wochenschr. 157, 331\u2013336. 10.1007/s10354-007-0434-6", "ArticleIdList": ["10.1007/s10354-007-0434-6", "17704982"]}, {"Citation": "Das S. K., Das V., Gulati A. K., Singh V. P. (1989). Deglycyrrhizinated liquorice in aphthous ulcers. J. Assoc. Phys. India 37 (10), 647.", "ArticleIdList": ["2632514"]}, {"Citation": "Di Matteo G., Spano M., Grosso M., Salvo A., Ingallina C., Russo M., et al. (2020). Food and COVID-19: preventive/Co-therapeutic strategies explored by current clinical trials and in silico studies. Foods 9 (8), 1036 10.3390/foods9081036", "ArticleIdList": ["10.3390/foods9081036", "PMC7466271", "32752217"]}, {"Citation": "Du L., He Y., Zhou Y., Liu S., Zheng B. J., Jiang S. (2009). The spike protein of SARS-CoV - a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7 (3), 226\u2013236. 10.1038/nrmicro2090", "ArticleIdList": ["10.1038/nrmicro2090", "PMC2750777", "19198616"]}, {"Citation": "Du L., Tai W., Zhou Y., Jiang S. (2016). Vaccines for the prevention against the threat of MERS-CoV. Expert Rev. Vacc. 15 (9), 1123\u20131134. 10.1586/14760584.2016.1167603", "ArticleIdList": ["10.1586/14760584.2016.1167603", "PMC5097835", "26985862"]}, {"Citation": "Du L., Yang Y., Zhou Y., Lu L., Li F., Jiang S. (2017). MERS-CoV spike protein: a key target for antivirals. Expert Opin. Ther. Targets 21 (2), 131\u2013143. 10.1080/14728222.2017.1271415", "ArticleIdList": ["10.1080/14728222.2017.1271415", "PMC5457961", "27936982"]}, {"Citation": "Dudani T., Saraogi A. (2020). Use of herbal medicines on coronavirus. Acta Sci. Pharm. Sci. 11 (6), 416\u2013419. 10.31080/asps.2020.04.0518", "ArticleIdList": ["10.31080/asps.2020.04.0518"]}, {"Citation": "Fiore C., Eisenhut M., Krausse R., Ragazzi E., Pellati D., Armanini D., et al. (2008). Antiviral effects of Glycyrrhiza species. Phyther. Res. 22 (2), 141\u2013148. 10.1002/ptr.2295", "ArticleIdList": ["10.1002/ptr.2295", "PMC7167979", "17886224"]}, {"Citation": "Fischer W. B., Thiel G., Fink R. H. A. (2010). Viral membrane proteins. Eur. Biophys. J. 39, 1041\u20131042. 10.1007/s00249-009-0525-y", "ArticleIdList": ["10.1007/s00249-009-0525-y", "19672588"]}, {"Citation": "Gan Y. R., Huang H., Huang Y. D., Rao C. M., Zhao Y., Liu J. S., et al. (2006). Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase. Peptides 27 (4), 622\u2013625. 10.1016/j.peptides.2005.09.006", "ArticleIdList": ["10.1016/j.peptides.2005.09.006", "PMC7115688", "16242214"]}, {"Citation": "Gao F., Ou H. Y., Chen L. L., Zheng W. X., Zhang C. T. (2003). Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes. FEBS Lett. 553 (3), 451\u2013456. 10.1016/S0014-5793(03)01091-3", "ArticleIdList": ["10.1016/S0014-5793(03)01091-3", "PMC7232748", "14572668"]}, {"Citation": "Gordon C. J., Tchesnokov E. P., Woolner E., Perry J. K., Feng J. Y., Porter D. P., et al. (2020). Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J. Biol. Chem. 295, 6785\u20136797. 10.1074/jbc.RA120.013679", "ArticleIdList": ["10.1074/jbc.RA120.013679", "PMC7242698", "32284326"]}, {"Citation": "Guo Y. R., Cao Q. D., Hong Z. S., Tan Y. Y., Chen S. D., Jin H. J., et al. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status. Mil. Med. Res. 226, 20\u201339. 10.1186/s40779-020-00240-0", "ArticleIdList": ["10.1186/s40779-020-00240-0", "PMC7068984", "32169119"]}, {"Citation": "Han Y. S., Chang G. G., Juo C. G., Lee H. J., Yen S. H., Hsu J. T. A., et al. (2005). Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. Biochemistry 44, 10349\u201310359. 10.1021/bi0504761", "ArticleIdList": ["10.1021/bi0504761", "16042412"]}, {"Citation": "Ho T. Y., Wu S. L., Chen J. C., Li C. C., Hsiang C. Y. (2007). Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 74 (2), 92\u2013101. 10.1016/j.antiviral.2006.04.014", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Hoever G., Baltina L., Michaelis M., Kondratenko R., Baltina L., Tolstikov G. A., et al. (2005). Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J. Med. Chem. 48 (4), 1256\u20131259. 10.1021/jm0493008", "ArticleIdList": ["10.1021/jm0493008", "15715493"]}, {"Citation": "Hogue B. G., Machamer C. E. (2014). Coronavirus structural proteins and virus assembly. In Nidoviruses 28, 569. 10.1128/9781555815790.ch12", "ArticleIdList": ["10.1128/9781555815790.ch12"]}, {"Citation": "Huang I. C., Bosch B. J., Li F., Li W., Kyoung H. L., Ghiran S., et al. (2006). SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 281 (6), 3198\u20133203. 10.1074/jbc.M508381200", "ArticleIdList": ["10.1074/jbc.M508381200", "PMC8010168", "16339146"]}, {"Citation": "Inoue Y., Tanaka N., Tanaka Y., Inoue S., Morita K., Zhuang M., et al. (2007). Clathrin-dependent entry of Severe Acute Respiratory Syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J. Virol. 81 (16), 8722\u20138729. 10.1128/jvi.00253-07", "ArticleIdList": ["10.1128/jvi.00253-07", "PMC1951348", "17522231"]}, {"Citation": "Jo S., Kim H., Kim S., Shin D. H., Kim M. S. (2019). Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem. Biol. Drug Des. 94 (6), 2023\u20132030. 10.1111/cbdd.13604", "ArticleIdList": ["10.1111/cbdd.13604", "PMC7162010", "31436895"]}, {"Citation": "Jo S., Kim S., Shin D. H., Kim M. S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzyme Inhib. Med. Chem. 35 (1), 145\u2013151. 10.1080/14756366.2019.1690480", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Kalliokoski T., Kramer C., Vulpetti A., Gedeck P. (2013). Comparability of mixed IC 50 data\u2013a statistical analysis. PloS One 8 (4), e61007 10.1371/journal.pone.0061007", "ArticleIdList": ["10.1371/journal.pone.0061007", "PMC3628986", "23613770"]}, {"Citation": "Kelly M. L., Cook J. A., Brown-Augsburger P., Heinz B. A., Smith M. C., Pinto L. H. (2003). Demonstrating the intrinsic ion channel activity of virally encoded proteins. FEBS (Fed. Eur. Biochem. Soc.) Lett. 552 (1), 61\u201367. 10.1016/S0014-5793(03)00851-2", "ArticleIdList": ["10.1016/S0014-5793(03)00851-2", "12972153"]}, {"Citation": "Khanna K., Kohli S. K., Kaur R., Bhardwaj A., Bhardwaj V., Ohri P., et al. (2020). Herbal immune-boosters: substantial warriors of pandemic Covid-19 battle. Phytomedicine 5, e561 10.1016/j.phymed.2020.153361", "ArticleIdList": ["10.1016/j.phymed.2020.153361", "PMC7532351", "33485605"]}, {"Citation": "Kim D. E., Min J. S., Jang M. S., Lee J. Y., Shin Y. S., Park C. M., et al. (2019). Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus oc43 infection of mrc-5 human lung cells. Biomolecules 9 (11), 696 10.3390/biom9110696", "ArticleIdList": ["10.3390/biom9110696", "PMC6921063", "31690059"]}, {"Citation": "Kim H. Y., Eo E. Y., Park H., Kim Y. C., Park S., Shin H. J., et al. (2010). Medicinal herbal extracts of Sophorae radix, Acanthopanacis cortex, Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro. Antivir. Ther. 15 (5), 697\u2013709. 10.3851/IMP1615", "ArticleIdList": ["10.3851/IMP1615", "20710051"]}, {"Citation": "Kim H. Y., Shin H. S., Park H., Kim Y. C., Yun Y. G., Park S., et al. (2008). In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex . J. Clin. Virol. 41 (2), 122\u2013128. 10.1016/j.jcv.2007.10.011", "ArticleIdList": ["10.1016/j.jcv.2007.10.011", "PMC7108295", "18036887"]}, {"Citation": "Kolodziej H. (2008). Aqueous ethanolic extract of the roots of Pelargonium sidoides - new scientific evidence for an old anti-infective phytopharmaceutical. Planta Med. 74 (6), 661\u2013666. 10.1055/s-2007-993778", "ArticleIdList": ["10.1055/s-2007-993778", "18203051"]}, {"Citation": "Korba B. E., Furman P. A., Otto M. J. (2006). Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo . Expert Rev. Anti Infect. Ther. 4, 549\u2013561. 10.1586/14787210.4.4.549", "ArticleIdList": ["10.1586/14787210.4.4.549", "17009935"]}, {"Citation": "Krausse R., Bielenberg J., Blaschek W., Ullmann U. (2004). In vitro anti-Helicobacter pylori activity of Extractum liquiritiae, glycyrrhizin and its metabolites. J. Antimicrob. Chemother. 54 (1), 243\u2013246. 10.1093/jac/dkh287", "ArticleIdList": ["10.1093/jac/dkh287", "15190039"]}, {"Citation": "Kr\u00fcger J., Fischer W. B. (2009). Assembly of viral membrane proteins. J. Chem. Theory Comput. 5, 2503\u20132513. 10.1021/ct900185n", "ArticleIdList": ["10.1021/ct900185n", "26616628"]}, {"Citation": "Ksiazek T. G., Erdman D., Goldsmith C. S., Zaki S. R., Peret T., Emery S., et al. (2003). A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348 (20), 1953\u20131966. 10.1056/NEJMoa030781", "ArticleIdList": ["10.1056/NEJMoa030781", "12690092"]}, {"Citation": "Kumar R., Harilal S., Al-Sehemi A. G., Mathew G. E., Carradori S., Mathew B. (2020). The Chronicle of COVID-19 and possible strategies to curb the pandemic. Curr. Med. Chem. 182, 111602 10.2174/0929867327666200702151018", "ArticleIdList": ["10.2174/0929867327666200702151018", "32614740"]}, {"Citation": "Lau K. M., Lee K. M., Koon C. M., Cheung C. S. F., Lau C. P., Ho H. M., et al. (2008). Immunomodulatory and anti-SARS activities of Houttuynia cordata . J. Ethnopharmacol. 118 (1), 79\u201385. 10.1016/j.jep.2008.03.018", "ArticleIdList": ["10.1016/j.jep.2008.03.018", "PMC7126383", "18479853"]}, {"Citation": "Li H., Wu J., Zhang Z., Ma Y., Liao F., Zhang Y., et al. (2011). Forsythoside A inhibits the avian infectious bronchitis virus in cell culture. Phyther. Res. 6, 1060\u20131069. 10.1002/ptr.3260", "ArticleIdList": ["10.1002/ptr.3260", "PMC7168103", "20677175"]}, {"Citation": "Li S. Y., Chen C., Zhang H. Q., Guo H. Y., Wang H., Wang L., et al. (2005). Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 67 (1), 18\u201323. 10.1016/j.antiviral.2005.02.007", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Li W., Moore M. J., Vasllieva N., Sui J., Wong S. K., Berne M. A., et al. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (6965), 450\u2013454. 10.1038/nature02145", "ArticleIdList": ["10.1038/nature02145", "PMC7095016", "14647384"]}, {"Citation": "Lin C. W., Tsai F. J., Tsai C. H., Lai C. C., Wan L., Ho T. Y., et al. (2005). Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 67, 18\u201323. 10.1016/j.antiviral.2005.07.002", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Lindner H. A., Fotouhi-Ardakani N., Lytvyn V., Lachance P., Sulea T., M\u00e9nard R. (2005). The papain-like protease from the Severe Acute Respiratory Syndrome coronavirus is a deubiquitinating enzyme. J. Virol. 79 (24), 15199\u201315208. 10.1128/jvi.79.24.15199-15208.2005", "ArticleIdList": ["10.1128/jvi.79.24.15199-15208.2005", "PMC1316033", "16306591"]}, {"Citation": "Ling C. (2020). Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). J. Integr. Med. 18 (2), 87\u201388. 10.1016/j.joim.2020.02.00", "ArticleIdList": ["10.1016/j.joim.2020.02.00", "PMC7129043", "32122812"]}, {"Citation": "Liu C., Zhou Q., Li Y., Garner L. V., Watkins S. P., Carter L. J., et al. (2020). Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent. Sci. 6 (3), 315\u2013331. 10.1021/acscentsci.0c00272", "ArticleIdList": ["10.1021/acscentsci.0c00272", "PMC10467574", "32226821"]}, {"Citation": "Liu S., Xiao G., Chen Y., He Y., Niu J., Escalante C. R., et al. (2004). Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363 (9413), 938\u2013947. 10.1016/S0140-6736(04)15788-7", "ArticleIdList": ["10.1016/S0140-6736(04)15788-7", "PMC7140173", "15043961"]}, {"Citation": "Lu W., Zheng B. J., Xu K., Schwarz W., Du L., Wong C. K. L., et al. (2006). Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc. Natl. Acad. Sci. USA 103 (33), 12540\u201312545. 10.1073/pnas.0605402103", "ArticleIdList": ["10.1073/pnas.0605402103", "PMC1567914", "16894145"]}, {"Citation": "Luo W., Su X., Gong S., Qin Y., Liu W., Li J., et al. (2009). Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Biosci. Trends 3 (4), 124\u2013126.", "ArticleIdList": ["20103835"]}, {"Citation": "Marra M. A., Jones S. J. M., Astell C. R., Holt R. A., Brooks-Wilson A., Butterfield Y. S. N., et al. (2003). The genome sequence of the SARS-associated coronavirus. Science 80, 231 10.1126/science.1085953", "ArticleIdList": ["10.1126/science.1085953", "12730501"]}, {"Citation": "Masters P. S. (2006). The molecular biology of coronaviruses. Adv. Virus Res. 66, 193\u2013292. 10.1016/S0065-3527(06)66005-3", "ArticleIdList": ["10.1016/S0065-3527(06)66005-3", "PMC7112330", "16877062"]}, {"Citation": "Mellman I. (1996). Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12, 575\u2013625. 10.1146/annurev.cellbio.12.1.575", "ArticleIdList": ["10.1146/annurev.cellbio.12.1.575", "8970738"]}, {"Citation": "Mercorelli B., Pal\u00f9 G., Loregian A. (2018). Drug repurposing for viral infectious diseases: how far are we?. Trends Microbiol. 26 (10), 865\u2013876. 10.1016/j.tim.2018.04.004", "ArticleIdList": ["10.1016/j.tim.2018.04.004", "PMC7126639", "29759926"]}, {"Citation": "Michaelis M., Doerr H. W., Cinatl J. (2011). Investigation of the influence of EPs\u00ae 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine 18 (5), 384\u2013386. 10.1016/j.phymed.2010.09.008", "ArticleIdList": ["10.1016/j.phymed.2010.09.008", "PMC7127141", "21036571"]}, {"Citation": "Milewska A., Zarebski M., Nowak P., Stozek K., Potempa J., Pyrc K. (2014). Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. J. Virol. 88 (22), 13221\u201313230 10.1128/jvi.02078-14", "ArticleIdList": ["10.1128/jvi.02078-14", "PMC4249106", "25187545"]}, {"Citation": "Mohajer Shojai T., Ghalyanchi Langeroudi A., Karimi V., Barin A., Sadri N. (2016). The effect of Allium sativum (Garlic) extract on infectious bronchitis virus in specific pathogen free embryonic egg. Avicenna J. phytomedicine 6, 458\u2013267. 10.22038/ajp.2016.6455", "ArticleIdList": ["10.22038/ajp.2016.6455", "PMC4967842", "27516987"]}, {"Citation": "Montal M. (2003). Structure-function correlates of Vpu, a membrane protein of HIV-1. FEBS (Fed. Eur. Biochem. Soc.) Lett. 552 (1), 47\u201353. 10.1016/S0014-5793(03)00849-4", "ArticleIdList": ["10.1016/S0014-5793(03)00849-4", "12972151"]}, {"Citation": "Nassiri Asl M., Hosseinzadeh H. (2008). Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phyther. Res. 22 (6), 709\u2013724. 10.1002/ptr.2362", "ArticleIdList": ["10.1002/ptr.2362", "PMC7167813", "18446848"]}, {"Citation": "Nishibe S., Okabe K., Tsukamoto H., Sakushima A., Hisada S. (1982). The structure of forsythiaside isolated from Forsythia suspensa . Chem. Pharm. Bull. 30, 1048\u20131050. 10.1248/cpb.30.1048", "ArticleIdList": ["10.1248/cpb.30.1048", "7168874"]}, {"Citation": "Patel A., Jernigan D. B. (2020). Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak \u2010 United States, December 31, 2019-February 4, 2020. MMWR Morb. Mortal. Wkly. Rep. 69 (5), 140\u2013146. 10.15585/mmwr.mm6905e1", "ArticleIdList": ["10.15585/mmwr.mm6905e1", "PMC7004396", "32027631"]}, {"Citation": "Raj V. S., Mou H., Smits S. L., Dekkers D. H. W., M\u00fcller M. A., Dijkman R., et al. (2013). Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 23, 1069\u20131070. 10.1038/nature12005", "ArticleIdList": ["10.1038/nature12005", "PMC7095326", "23486063"]}, {"Citation": "Ramos-Tovar E., Muriel P. (2019). \u201cPhytotherapy for the liver,\u201d in Dietary intervention in liver diseases. Editors Watson R.R., Preedy V.R. (New York, NY: Acaddemic Press; ). 10.1016/B978-0-12-814466-4.00009-4", "ArticleIdList": ["10.1016/B978-0-12-814466-4.00009-4"]}, {"Citation": "Ruan Y. J., Wei C. L., Ee L. A., Vega V. B., Thoreau H., Yun S. T. S., et al. (2003). Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361, 1779\u20131785. 10.1016/S0140-6736(03)13414-9", "ArticleIdList": ["10.1016/S0140-6736(03)13414-9", "PMC7140172", "12781537"]}, {"Citation": "Ruch T. R., Machamer C. E. (2012). The coronavirus E protein: assembly and beyond. Viruses 8, 339 10.3390/v4030363", "ArticleIdList": ["10.3390/v4030363", "PMC3347032", "22590676"]}, {"Citation": "Rut W., Groborz K., Zhang L., Sun X., Zmudzinski M., Hilgenfeld R., et al. (2020). Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design. bioRxiv. 10, 521 10.1101/2020.03.07.981928", "ArticleIdList": ["10.1101/2020.03.07.981928"]}, {"Citation": "Sayre L. (1907). A manual of organic materia medica and pharmacognosy: an introduction to the study of the vegetable kingdom and the vegetable and animal drugs."}, {"Citation": "Schwarz S., Sauter D., L\u00fc W., Wang K., Sun B., Efferth T., et al. (2012). Coronaviral ion channels as target for Chinese herbal medicine. For. Immunopathol. Dis. Therap. 25, 6789 10.1615/ForumImmunDisTher.2012004378", "ArticleIdList": ["10.1615/ForumImmunDisTher.2012004378"]}, {"Citation": "Simmons G., Gosalia D. N., Rennekamp A. J., Reeves J. D., Diamond S. L., Bates P. (2005). Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA 102 (33), 11876\u201311881. 10.1073/pnas.0505577102", "ArticleIdList": ["10.1073/pnas.0505577102", "PMC1188015", "16081529"]}, {"Citation": "Smith R. A., Sidwell R. W., Robins R. K. (1980). Antiviral mechanisms of action. Annu. Rev. Pharmacol. Toxicol. 20, 259\u2013284. 10.1146/annurev.pa.20.040180.001355", "ArticleIdList": ["10.1146/annurev.pa.20.040180.001355", "6992699"]}, {"Citation": "Snijder E. J., Bredenbeek P. J., Dobbe J. C., Thiel V., Ziebuhr J., Poon L. L. M., et al. (2003). Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331 (5), 991\u20131004. 10.1016/S0022-2836(03)00865-9", "ArticleIdList": ["10.1016/S0022-2836(03)00865-9", "PMC7159028", "12927536"]}, {"Citation": "Song J., Shim J., Choi H. (2011). Quercetin 7-rhamnoside reduces porcine epidemic diarrhea virus replication via independent pathway of viral induced reactive oxygen species. Virol. J. 8, 460. 10.1186/1743-422X-8-460", "ArticleIdList": ["10.1186/1743-422X-8-460", "PMC3200163", "21967756"]}, {"Citation": "Stahlmann R., Lode H. (2020). Medication for COVID-19\u2014an overview of approaches currently under study. Dtsch. Arztebl. Int. 117, 213\u2013219. 10.3238/arztebl.2020.0213", "ArticleIdList": ["10.3238/arztebl.2020.0213", "PMC7196844", "32343658"]}, {"Citation": "Stang E., Blystad F. D., Kazazic M., Bertelsen V., Brodahl T., Raiborg C., et al. (2004). Cb1-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits. Mol. Biol. Cell 14, 289\u2013293. 10.1091/mbc.E04-01-0041", "ArticleIdList": ["10.1091/mbc.E04-01-0041", "PMC491821", "15194809"]}, {"Citation": "Thiel V., Ivanov K. A., Putics \u00c1., Hertzig T., Schelle B., Bayer S., et al. (2003). Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84 (Pt 9), 2305\u20132315. 10.1099/vir.0.19424-0", "ArticleIdList": ["10.1099/vir.0.19424-0", "12917450"]}, {"Citation": "Toney J. H., Navas-Mart\u00edn S., Weiss S. R., Koeller A. (2004). Sabadinine: a Potential non-peptide anti-Severe Acute-Respiratory-Syndrome agent identified using structure-aided design. J. Med. Chem. 47 (5), 1079 10.1021/jm034137m", "ArticleIdList": ["10.1021/jm034137m", "14971887"]}, {"Citation": "Tsai Y.-C., Lee C.-L., Yen H.-R., Chang Y.-S., Lin Y.-P., Huang S.-H., et al. (2020). Antiviral action of tryptanthrin isolated from Strobilanthes cusia leaf against human coronavirus NL63 outbreak of novel coronavirus (SARS-Cov-2): first evidences from international scientific literature and pending questions. Biomolecules 10 (3), 366 10.3390/biom10030366", "ArticleIdList": ["10.3390/biom10030366", "PMC7175275", "32120929"]}, {"Citation": "Vellingiri B., Jayaramayya K., Iyer M., Narayanasamy A., Govindasamy V., Giridharan B., et al. (2020). COVID-19: a promising cure for the global panic. Sci. Total Environ. 725, 138277 10.1016/j.scitotenv.2020.138277", "ArticleIdList": ["10.1016/j.scitotenv.2020.138277", "PMC7128376", "32278175"]}, {"Citation": "Wang C., Horby P. W., Hayden F. G., Gao G. F. (2020a). A novel coronavirus outbreak of global health concern. Lancet 395 (10223), 470\u2013473. 10.1016/S0140-6736(20)30185-9", "ArticleIdList": ["10.1016/S0140-6736(20)30185-9", "PMC7135038", "31986257"]}, {"Citation": "Wang K., Xie S., Sun B. (2011). Viral proteins function as ion channels. Biochim. Biophys. Acta Biomembr. 1808 (2), 510\u2013515. 10.1016/j.bbamem.2010.05.006", "ArticleIdList": ["10.1016/j.bbamem.2010.05.006", "PMC7094589", "20478263"]}, {"Citation": "Wang N., Shang J., Jiang S., Du L. (2020b). Subunit vaccines against emerging pathogenic human coronaviruses. Front. Microbiol. 11, 298 10.3389/fmicb.2020.00298", "ArticleIdList": ["10.3389/fmicb.2020.00298", "PMC7105881", "32265848"]}, {"Citation": "Wang Q., Wong G., Lu G., Yan J., Gao G. F. (2016). MERS-CoV spike protein: targets for vaccines and therapeutics. Antiviral Res. 133, 165\u2013177. 10.1016/j.antiviral.2016.07.015", "ArticleIdList": ["10.1016/j.antiviral.2016.07.015", "PMC7113765", "27468951"]}, {"Citation": "Wang S. Q., Du Q. S., Zhao K., Li A. X., Wei D. Q., Chou K. C. (2007). Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. Amino Acids 33 (1), 129\u2013135. 10.1007/s00726-006-0403-1", "ArticleIdList": ["10.1007/s00726-006-0403-1", "PMC7087620", "16998715"]}, {"Citation": "Weng J. R., Lin C. S., Lai H. C., Lin Y. P., Wang C. Y., Tsai Y. C., et al. (2019). Antiviral activity of Sambucus formosana Nakai ethanol extract and related phenolic acid constituents against human coronavirus NL63. Virus Res. 273, 197767. 10.1016/j.virusres.2019.197767", "ArticleIdList": ["10.1016/j.virusres.2019.197767", "PMC7114872", "31560964"]}, {"Citation": "World Health Organization (2004). SARS: clinical trials on treatment using a combination of traditional Chinese medicine and Western medicine. Beijing: World Health Organization."}, {"Citation": "Wu A., Peng Y., Huang B., Ding X., Wang X., Niu P., et al. (2020). Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 27 (3), 325\u2013328. 10.1016/j.chom.2020.02.001", "ArticleIdList": ["10.1016/j.chom.2020.02.001", "PMC7154514", "32035028"]}, {"Citation": "Wu C. Y., Jan J. T., Ma S. H., Kuo C. J., Juan H. F., Cheng Y. S. E., et al. (2004). Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. USA 101 (27), 10012\u201310017. 10.1073/pnas.0403596101", "ArticleIdList": ["10.1073/pnas.0403596101", "PMC454157", "15226499"]}, {"Citation": "Yang G., Zhang H., Yang Y. (2020). Challenges and countermeasures of integrative cancer therapy in the epidemic of COVID-19. Integr. Cancer Ther. 9, 1534 10.1177/1534735420912811", "ArticleIdList": ["10.1177/1534735420912811", "PMC7079301", "32178547"]}, {"Citation": "Yin J., Li G., Li J., Yang Q., Ren X. (2011). In vitro and in vivo effects of Houttuynia cordata on infectious bronchitis virus. Avian Pathol. 40 (5), 491\u2013498. 10.1080/03079457.2011.605107", "ArticleIdList": ["10.1080/03079457.2011.605107", "21848486"]}, {"Citation": "Zhang D. hai, Wu, K. lun., Zhang X., Deng S. qiong., Peng B. (2020). In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integr. Med. 18 (2), 152\u2013158. 10.1016/j.joim.2020.02.005", "ArticleIdList": ["10.1016/j.joim.2020.02.005", "PMC7102521", "32113846"]}, {"Citation": "\nZhou J., Xie G., Yan X. (2011). Natural sources and applications molecular structures, pharmacological activities, encyclopedia of traditional Chinese medicines. Available at: https://link.springer.com/content/pdf/10.1007/978-3-642-16744-7.pdf (Accessed April 14, 2020).", "ArticleIdList": ["10.1007/978-3-642-16744-7.pdf"]}, {"Citation": "Zhou P., Yang X., Hu B., Zhang L., Zhang W. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 17 (8), 677\u2013686. 10.1038/s41586-020-2012-7", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Zhou Y., Jiang S., Du L. (2018). Prospects for a MERS-CoV spike vaccine. 17 (8), 677\u2013686. Expert Rev. Vaccines. 10.1080/14760584.2018.1506702", "ArticleIdList": ["10.1080/14760584.2018.1506702", "PMC6355461", "30058403"]}, {"Citation": "Zhu Z., Lian X., Su X., Wu W., Marraro G. A., Zeng Y. (2020). From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir. Res. 21, 224 10.1186/s12931-020-01479-w", "ArticleIdList": ["10.1186/s12931-020-01479-w", "PMC7450684", "32854739"]}, {"Citation": "Zhuang M., Jiang H., Suzuki Y., Li X., Xiao P., Tanaka T., et al. (2009). Procyanidins and butanol extract of Cinnamomi cortex inhibit SARS-CoV infection. Antiviral Res. 82 (1), 73\u201381. 10.1016/j.antiviral.2009.02.001", "ArticleIdList": ["10.1016/j.antiviral.2009.02.001", "PMC7114128", "19428598"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "8", "Day": "4"}, {"Year": "2020", "Month": "12", "Day": "3"}, {"Year": "2021", "Month": "2", "Day": "1", "Hour": "5", "Minute": "54"}, {"Year": "2021", "Month": "2", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "2", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "1", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["33519449", "PMC7845143", "10.3389/fphar.2020.589044", "589044"]}}], "PubmedBookArticle": []}